Nanocarriers for nitric oxide delivery.

Area of Science:

• Biomedical engineering
• Pharmaceutical sciences
• Nanomedicine

Background:

• Nitric oxide (NO) exhibits significant vasodilative, antibacterial, and tumoricidal properties, making it a promising pharmaceutical agent.
• Numerous synthetic compounds have been developed to stabilize and control the release of NO for therapeutic purposes.
• Current applications of NO are hindered by its short half-life, instability, potential toxicity, and challenges in controlled in vivo delivery.

Purpose of the Study:

• To explore strategies for enhancing the therapeutic utility of nitric oxide (NO) donors.
• To address the limitations of NO delivery, including stability, toxicity, and controlled administration.
• To investigate the potential of nanotechnology in improving NO-based therapeutics.

Main Methods:

• Development of synthetic compounds for controlled NO release (e.g., nitrosothiols, N-diazeniumdiolates).
• Evaluation of NO donor stability, toxicity, and delivery methods.
• Exploration of nanotechnology-based approaches for NO delivery.

Main Results:

• Synthetic NO donors offer controlled release but face inherent limitations.
• Challenges in NO delivery include short half-life, instability, and dose control.
• Nanotechnology is identified as a key strategy to overcome these limitations.

Conclusions:

• Nanotechnology offers a viable strategy to enhance the stability and delivery of nitric oxide (NO) donors.
• Overcoming NO delivery challenges through nanotechnology can significantly increase its therapeutic applicability.
• Further research into nanocarrier systems is crucial for advancing NO-based therapies.